Malignant skeletal pain: Mechanisms and potential therapeutic opportunities

Monica Herrera, Juan Miguel Jimenez-Andrade, Marina Vardanyan, Patrick W. Mantyh

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

For the first time, animal models of cancer pain are now available and effectively mirror the clinical picture observed in humans with bone cancer pain. Information generated from these models has begun to provide insight into the mechanisms that generate and maintain bone cancer pain and helped target potential mechanism-based therapies to treat this chronic pain state. It is noteworthy that in these models analgesics such as a bisphosphonate, osteoprotegerin and a cyclooxygenase-2 inhibitor appear to influence disease progression in the tumor-bearing bone. Together these and other studies using models of bone cancer suggest that it may be possible to develop novel mechanism-based therapies that not only reduce tumor-induced bone pain but may provide added benefit in synergistically reducing disease progression. Successful development and clinical use of these therapies has the potential not only to positively impact survival, but also to improve the cancer patient's quality of life.

Original languageEnglish (US)
Title of host publicationBone Cancer
PublisherElsevier Inc.
Pages321-332
Number of pages12
ISBN (Print)9780123748959
DOIs
StatePublished - Dec 1 2010

ASJC Scopus subject areas

  • Dentistry(all)
  • Medicine(all)

Fingerprint Dive into the research topics of 'Malignant skeletal pain: Mechanisms and potential therapeutic opportunities'. Together they form a unique fingerprint.

  • Cite this

    Herrera, M., Jimenez-Andrade, J. M., Vardanyan, M., & Mantyh, P. W. (2010). Malignant skeletal pain: Mechanisms and potential therapeutic opportunities. In Bone Cancer (pp. 321-332). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-374895-9.00027-X